Therapeutic effect of nerve growth factor on canine cerebral infarction evaluated by MRI
Metrics: PDF 356 views | HTML 721 views | ?
Yong Wang1, Hui Zhang2, Zhe Wang3, Huaijun Liu1, Xin Tian1, Jian Yu1 and Chaoxu Chen1
1Department of Radiology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province 050000, China
2Department of Radiology, Hebei General Hospital, Shijiazhuang, Hebei Province 050051, China
3Department of Computer Science, Clinical College of Hebei Medical University, Shijiazhuang, Hebei Province 050031, China
Yong Wang, email: email@example.com
Keywords: nerve growth factor; canine middle cerebral artery occlusion; magnetic resonance imaging; diffusion-weighted imaging; perfusion-weighted imaging
Received: September 22, 2017 Accepted: November 16, 2017 Published: December 16, 2017
To explore therapeutic effect of nerve growth factor (NGF) on cerebral infarction by establishing canine middle cerebral artery occlusion (MCAO) infarct model. The magnetic resonance imaging (MRI) technology was used to study effects of NGF on cerebral infarction, and the results of MRI indexes (such as diffusion-weighted imaging (DWI) and perfusion-weighted imaging (PWI)) were compared with the results of pathology, cell biology and molecular biology. The clinical manifestations of the canine infarction model treated by NGF were significantly improved within 7 days compared with control group. The therapeutic evaluation of NGF effect could be determine by canine cerebral infarction treated by NGF within 6 hours according to DWI and PWI. From 6 hours to 7 days, therapeutic evaluation of NGF could be determine by T1WI, T2WI and FLAIR. DWI and PWI could find the change of cerebral ischemia at the early stage, provide advantages for qualitative diagnosis of early-stage cerebral infarction and observation of efficacy in early treatment, initially showing that their great potential for NGF role on cerebral ischemia and mechanism.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.